COMMUNIQUÉS West-GlobeNewswire

SubioMed™ Enters Dynamic Biomechanics Market from Minneapolis
13/05/2019
Company Founded on Patented Inventions by Dr. Barry Butler, DPM Practicing Podiatrist and Serial Inventor MINNEAPOLIS, May 13, 2019 (GLOBE NEWSWIRE) -- SubioMed, Inc. (“SubioMed” or the “Company”), a pioneer in the [...]
NRC Health Announces Winners of the 2019 Customer and Employee Approved Awards Among Senior Living Communities
13/05/2019
Public perception of senior care is still low, but NRC Health data shows that 88% of senior living customers are happy with their care experiences LINCOLN, Neb., May 13, 2019 (GLOBE NEWSWIRE) -- NRC Health , the leading [...]
ARCA biopharma Announces Submission of Patent Application to U.S. Patent and Trademark Office Covering Treatment of Atrial Fibrillation in Patients With Heart Failure
13/05/2019
Similar Applications to Be Filed in Europe, Canada, Japan and China WESTMINSTER, Colo., May 13, 2019 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine [...]
Cannabix Technologies Adds Dr. Randall Purves as Scientific Advisor
13/05/2019
The Cannabix Marijuana Breathalyzer system is being developed to give law enforcement and employers a tool to enforce public safety. VANCOUVER, British Columbia, May 13, 2019 (GLOBE NEWSWIRE) -- Cannabix Technologies [...]
Arbutus to Present at Upcoming May 2019 Conferences
13/05/2019
WARMINSTER, Pa., May 13, 2019 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that Dr. Mark J. Murray, Arbutus [...]
Auris Medical Holding Ltd.:
13/05/2019
Auris Medical Prices $8,000,000 Public Offering Hamilton, Bermuda, May 13, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address [...]
Uptick Newswire Hosts Avivagen Inc. on The Stock Day Podcast to Discuss Upcoming Milestones in The Livestock Additive Space
13/05/2019
PHOENIX, May 13, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed Avivagen Inc. (CHEXF) , a life sciences corporation focused on developing and commercializing products for livestock, companion animal [...]
Hemispherx Announces Progress Toward Opening of Prostate Cancer Study at Roswell Park Comprehensive Cancer Center
13/05/2019
OCALA, Fla., May 13, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma Inc., (NYSE American: HEB), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers and [...]
Bellerophon to Present Additional Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at American Thoracic Society 115th International Conference
13/05/2019
Results to be Presented in Late-Breaking Abstract as an Oral Presentation Company will Also Present a Corporate Overview and Update on its PH-ILD Program at Respiratory Innovation Summit WARREN, N.J., May 13, 2019 ( [...]
Aptose to Present at May Investor Conferences
13/05/2019
SAN DIEGO and TORONTO, May 13, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage biotechnology company developing first-in-class agents that target the dysregulated processes [...]
Minerva Neurosciences Announces Positive Top Line Results in Phase 2b Clinical Trial With Seltorexant (MIN-202) in Treatment of Depressed Patients With an Inadequate Response to SSRIs and SNRIs
13/05/2019
Potential first-in-class, oral specific orexin- 2 inhibitor demonstrates statistically significant improvement in MADRS scores at 6 weeks compared to placebo Well tolerated, with adverse events similar to or lower than [...]
iTeos Therapeutics to Present at UBS Global Healthcare Conference
13/05/2019
iTeos Therapeutics to Present at UBS Global Healthcare Conference Gosselies, Belgium and Cambridge, MA – May 13, 2019 – iTeos Therapeutics SA, a privately-held biotechnology company developing novel cancer [...]
Rexahn Pharmaceuticals Reports First Quarter 2019 Financial Results
13/05/2019
ROCKVILLE, Md., May 13, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that [...]
HempAmericana Commences Bottling on Full Spectrum Distillate CBD in Maine Laboratory
13/05/2019
NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”) is pleased to announce that it has commenced bottling 500mg and 1000mg full spectrum CBD [...]
resTORbio to Present RTB101 Phase 2b Clinical Trial Data at American Thoracic Society 2019 International Conference
13/05/2019
BOSTON, May 13, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC) today announced that it will present additional results from the Phase 2b trial evaluating RTB101 (dactolisib), an oral, selective, and potent [...]
WW to Present at Goldman Sachs Global Staples Forum
13/05/2019
NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- Weight Watchers International, Inc. (Nasdaq: WW), a global wellness company and the world’s leading commercial weight management program, today announced that Mindy Grossman, [...]
Neon Therapeutics Reports First Quarter 2019 Financial Results and Provides Clinical Update
13/05/2019
Advancing a class-leading position in neoantigen-based therapies with ongoing progress across its multiple clinical-stage programs, pre-clinical pipeline and bioinformatics engine Expect to report in July top-line [...]
Tonix Pharmaceuticals Reports First Quarter 2019 Financial Results and Operational Highlights
13/05/2019
Phase 3 RECOVERY Trial of Tonmya® for the Treatment of PTSD is Enrolling; Topline Data Expected First Half of 2020 NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or [...]
Mustang Bio to Present at the Cell & Gene Therapy USA Congress 2019
13/05/2019
NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into [...]

Pages